FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Victor Sandor

Research Profile

Chemicals & Drugs

Anatomy

Tumor Cells, Cultured

Disorders

Physiology

Concepts & Ideas

Procedures

Co-author Network

Publications

TOP 3
P James Scrivens; Moulay A Alaoui-Jamali; Giuseppe Giannini; Taiqi Wang; Martin Loignon; Gerald Batist; Victor A Sandor
Cdc25A-inhibitory properties and antineoplastic activity of bisperoxovanadium analogues.
Lawrence Panasci; S F Stinson; D Melnychuk; Victor A Sandor; W H Miller; Gerald Batist; François Patenaude; N Bangash; L Panarello; Moulay A Alaoui-Jamali; Edward A Sausville
SarCNU, a nitrosourea analog on a day 1, 5, and 9 oral schedule: a phase I and pharmacokinetic study in patients with advanced solid tumors.
Victor A Sandor; Susan Bakke; Robert W Robey; Min H Kang; Mikhail V Blagosklonny; Jonathon Bender; Rebecca Brooks; Richard L Piekarz; Eben Tucker; William D Figg; Kenneth K Chan; Barry Goldspiel; Antonio Tito Fojo; Stanley P Balcerzak; Susan E Bates
Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Victor Sandor (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2003: P James Scrivens; Moulay A Alaoui-Jamali; Giuseppe Giannini; Taiqi Wang; Martin Loignon; Gerald Batist; Victor A Sandor
Cdc25A-inhibitory properties and antineoplastic activity of bisperoxovanadium analogues.
Molecular cancer therapeutics 2003;2(10):1053-9.
2003: Lawrence Panasci; S F Stinson; D Melnychuk; Victor A Sandor; W H Miller; Gerald Batist; François Patenaude; N Bangash; L Panarello; Moulay A Alaoui-Jamali; Edward A Sausville
SarCNU, a nitrosourea analog on a day 1, 5, and 9 oral schedule: a phase I and pharmacokinetic study in patients with advanced solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(2):232-40.
2002: Victor A Sandor; Susan Bakke; Robert W Robey; Min H Kang; Mikhail V Blagosklonny; Jonathon Bender; Rebecca Brooks; Richard L Piekarz; Eben Tucker; William D Figg; Kenneth K Chan; Barry Goldspiel; Antonio Tito Fojo; Stanley P Balcerzak; Susan E Bates
Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(3):718-28.
2001: Richard L Piekarz; Robert W Robey; Victor A Sandor; Susan Bakke; Wyndham H Wilson; L Dahmoush; D M Kingma; Maria L Turner; Rosemary M Altemus; Susan E Bates
Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: a case report.
Blood 2001;98(9):2865-8.
2000: Victor A Sandor; Adrian M Senderowicz; Susan D Mertins; Dan L Sackett; Edward A Sausville; Mikhail V Blagosklonny; Susan E Bates
P21-dependent g(1)arrest with downregulation of cyclin D1 and upregulation of cyclin E by the histone deacetylase inhibitor FR901228.
British journal of cancer 2000;83(6):817-25.
2000: S Javaheri; Victor Cohen; I Libman; Victor A Sandor
Life-threatening tinnitus.
Lancet 2000;356(9226):308.
2000: Victor A Sandor; A R Robbins; Robert W Robey; T Myers; Edward A Sausville; Susan E Bates; Dan L Sackett
FR901228 causes mitotic arrest but does not alter microtubule polymerization.
Anti-cancer drugs 2000;11(6):445-54.
1999: Victor A Sandor; Eddie Reed; Gisele Sarosy; L P Middleton; P Davis; Elise C Kohn
Synchronous inflammatory breast cancer and advanced ovarian carcinoma: a case with prolonged disease-free survival.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(5):585-8.
1998: Lawrence Panasci; Victor A Sandor; D Melnychuk
Clodronate in metastatic breast cancer.
The New England journal of medicine 1998;339(26):1940-1; author reply 1941.
1998: M Alvarez; Robert W Robey; Victor A Sandor; K Nishiyama; Y Matsumoto; K Paull; S Bates; Tito Fojo
Using the national cancer institute anticancer drug screen to assess the effect of MRP expression on drug sensitivity profiles.
Molecular pharmacology 1998;54(5):802-14.
1998: Victor A Sandor; V Stark-Vancs; Deborah Pearson; R Nussenblat; Scott M Whitcup; Pim Brouwers; N Patronas; John D Heiss; Elaine S Jaffe; M deSmet; David R Kohler; Richard Simon; Robert Wittes
Phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(9):3000-6.
1998: Victor A Sandor; Tito Fojo; Susan E Bates
Future perspectives for the development of P-glycoprotein modulators.
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 1998;1(3):190-200.
1997: Victor A Sandor; W Wilson; Tito Fojo; Susan E Bates
The role of MDR-1 in refractory lymphoma.
Leukemia & lymphoma 1997;28(1-2):23-31.
1997: Zhirong Zhan; Victor A Sandor; E Gamelin; JT Regis; B Dickstein; W Wilson; Antonio Tito Fojo; Susan E Bates
Expression of the multidrug resistance-associated protein gene in refractory lymphoma: quantitation by a validated polymerase chain reaction assay.
Blood 1997;89(10):3795-800.
1996: Victor A Sandor; R Hassan; E Kohn
Exacerbation of pseudogout by granulocyte colony-stimulating factor.
Annals of internal medicine 1996;125(9):781.